1. A NOVEL PATHOGENIC SH2D1A MUTATION CAUSES X-LINKED LYMPHOPROLIFERATIVE DISEASE MANIFESTED BY NON-HODGKIN LYMPHOMA AND DYSGAMMAGLOBULINEMIA. (October 2022) Authors: Gilad, G.; Shichrur, K.; Laiba, E.; Birger, Y.; Jaron, R.; Elitzur, S.; Avrahami, G.; Barzilai-Birenboim, S.; Yanir, A.; Krauss, A.; Stein, J.; Kodman, Y.; Feuerstein, T.; Marcus, N.; Izraeli, S. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Optimizing the process of fertility preservation in pediatric female cancer patients – a multidisciplinary program. Issue 1 (December 2016) Authors: Ben-Aharon, Irit; Abir, R.; Perl, G.; Stein, J.; Gilad, G.; Toledano, H.; Elitzur, S.; Avrahami, G.; Ben-Haroush, A.; Oron, G.; Freud, E.; Kravarusic, D.; Ben-Arush, M.; Herzel, G.; Yaniv, I.; Stemmer, S.; Fisch, B.; Ash, S. Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P360: EFFICACY AND SAFETY OF DARATUMUMAB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR LYMPHOBLASTIC LYMPHOMA: RESULTS FROM PHASE 2 DELPHINUS STUDY. (23rd June 2022) Authors: Vora, A.; Bhatla, T.; Teachey, D.; Bautista, F.; Moppett, J.; Velasco Puyó, P.; Micalizzi, C.; Rossig, C.; Shukla, N.; Gilad, G.; Locatelli, F.; Baruchel, A.; Zwaan, C. M.; Raetz, E. A.; Bandyopadhyay, N.; Lopez Solano, L.; Dennis, R. M.; Carson, R.; Hogan, L. E. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗